The goal of this program is to improve management of mantle cell lymphoma (MCL) and treatment of myeloproliferative neoplasms (MPNs). After hearing and assimilating this program, the clinician will be better able to: 1. Cite evidence showing effectiveness of ibrutinib in management of MCL. 2. Optimize management of MCL in patients who are transplant ineligible. 3. Use brexucabtagene autoleucel in the management of MCL. 4. Compare use of ropeginterferon alfa-2b with phlebotomy in treatment of polycythemia vera. 5. List adverse events associated with use of bomedemstat in management of essential thrombocythemia.
- Provider:Lippincott Continuing Medical Education Institute, Inc.
- Activity Link: https://www.audio-digest.org/Specialties/Oncology
- Start Date: 2023-06-26 05:00:00
- End Date: 2023-06-26 05:00:00
- Credit Details: AMA PRA Category 1 Credit™️: 2.0 hours
- MOC Credit Details: ABIM - 2.0 Point; Credit Type(s): Medical Knowledge (ABIM)
- Commercial Support: No
- Activity Type: Enduring Material
- CME Finder Type: Online Learning
- Fee to Participate: Yes
- Measured Outcome: Learner Competence, Learner Knowledge, Learner Performance
- Provider Ship: Directly Provided
- Registration: Open to all
- Specialty: Medical Oncology
Subscribe
Login
0 Comments
Oldest